Company Search:
Advanced Search
Sponsored Links
Silence Therapeutics Plc Company Snapshot
Silence Therapeutics Plc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Silence Therapeutics Plc with three other miscellaneous service companies in Europe: Nordic Nanovector Asa of NORWAY (2017 sales of 302,000.00 Norwegian Kroner [US$28,092.04 ] ), Immunovia AB (publ) of SWEDEN (148,963.00 Swedish Kronor [US$14,724.99 ] ), and Oryzon Genomics Sa which is based in SPAIN (16,764.00 Euros [US$18,241.58 ] ).

Sales Analysis.
  Stock Performance Chart for Silence Therapeutics Plc
  Stock Data: Recent Stock Performance:
  Current Price (3/27/2020): 486.00p
(Figures in Pounds Sterling)
1 Week 20.9%   13 Weeks 16.8%  
4 Weeks 21.5%   52 Weeks 1,040.8%  
Silence Therapeutics Plc Key Data:
  Ticker: SLN Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 16,000
(Year Ending Jan 2018).
Employees: 45
  Currency: Pounds Sterling Market Cap: 350,714,537
  Fiscal Yr Ends: December Shares Outstanding: 72,163,485
  Share Type: Ordinary Closely Held Shares: 37,420,475
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.